Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 56.90B KRW in the quarter ending June 30, 2025, with 3.66% growth. This brings the company's revenue in the last twelve months to 215.10B, up 5.29% year-over-year. In the year 2024, Sam Chun Dang Pharm. had annual revenue of 210.92B with 9.47% growth.

• Revenue (ttm): 215.10B
• Revenue Growth: +5.29%
• P/S Ratio: 24.54
• Revenue / Employee: 513.35M
• Employees: 419
• Market Cap: 5,279.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	210.92B	18.26B	9.47%
Dec 31, 2023	192.67B	15.33B	8.65%
Dec 31, 2022	177.34B	10.06B	6.01%
Dec 31, 2021	167.27B	412.57M	0.25%
Dec 31, 2020	166.86B	-19.74B	-10.58%